Skip to main content

ADVERTISEMENT

value framework

Perspectives
08/02/2016
Joshua P Cohen, PhD
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
...
08/02/2016
Journal of Clinical Pathways
06/20/2016
JCP Editors
In “What’s Next for Value-Frameworks in the U.S.?” a key session at ISPOR 2016, Lowell E Schnipper, MD, chair of the American Society of Clinical Oncology (ASCO), began by discussing why ASCO made the decision to...
In “What’s Next for Value-Frameworks in the U.S.?” a key session at ISPOR 2016, Lowell E Schnipper, MD, chair of the American Society of Clinical Oncology (ASCO), began by discussing why ASCO made the decision to...
In...
06/20/2016
Journal of Clinical Pathways
06/07/2016
JCP Editors
Anne C Chiang, MD, PhD, Yale School of Medicine (New Haven, CT), spoke first at the “Quality and Value: Measuring and Utilizing Both in Your Practice” session at the 2016 American Society of Clinical Oncology Annual...
Anne C Chiang, MD, PhD, Yale School of Medicine (New Haven, CT), spoke first at the “Quality and Value: Measuring and Utilizing Both in Your Practice” session at the 2016 American Society of Clinical Oncology Annual...
Anne C...
06/07/2016
Journal of Clinical Pathways